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Cardiotonic steroids (CTS) like ouabain are not only specific inhibitors of the sodium pump (Na+,K+-ATPase), they also can influence various
cytosolic signaling events in a hormone-like manner. In the neuroblastoma cell line SH-SY5Y ouabain triggers multiple signaling pathways.
Within 30 min of incubation with 1 or 10 μM ouabain, SH-SY5Y cells generate reactive oxygen species to a level approximately 50% above
control and show a modest but significant elevation in cytosolic [Ca2+] of about 25%. After 6 h of exposure, ouabain stimulates a series of anti-
apoptotic actions in SH-SY5Y cells, including concentration-dependent phosphorylation of Erk1/2, Akt, and Bad. Nevertheless, at the same time
this CTS also induces a series of events that inhibit retinoic acid–induced neuritogenesis and promote cell death. Both of these latter phenomena
are possibly associated with the observed ouabain-induced reduction in the abundance of the anti-apoptotic proteins Bcl-XL and Bcl-2. In
addition, ouabain treatment results in cytochrome c release into the cytosol and induces activation of caspase 3, events that point towards the
stimulation of apoptotic pathways that are probably enhanced by the stimulation of p53 phosphorylation at Ser15 also observed in this study.
These pathways may eventually lead to cell death: treatment with 10 nM ouabain results in a 20% decrease in cell number after 4 days of
incubation and treatment with 1 μM ouabain decreases cells number by about 75%. The results obtained here emphasize the importance of further
research in order to elucidate the various signalling cascades triggered by ouabain and possibly other CTS that are used in the treatment of heart
failure and to identify their primary receptor(s).
© 2007 Elsevier B.V. All rights reserved.Keywords: Ouabain; Cell signalling; Na+,K+-ATPase; Apoptosis; Neuroblastoma; p531. Introduction
Cardiotonic steroids (CTS) are used to induce positive
inotropy in the heart of patients with congestive heart failure
and cardiac arrhythmias. The molecular basis of the positive
inotropic effect has been linked to the inhibition of the sodium
pump (Na+,K+-ATPase), a membrane-bound enzyme that
pumps 3 Na+ ions out of the cell and 2 K+ ions into the cell
for each ATP hydrolyzed. Probably it is the inhibition of the
sodium pump that reduces the sodium gradient and therefore
indirectly influences the activity of the Na+/Ca2+-exchanger,⁎ Corresponding author. Tel.: +49 641 9938172; fax: +49 641 9938179.
E-mail address: Georgios.Scheiner-Bobis@vetmed.uni-giessen.de
(G. Scheiner-Bobis).
0005-2736/$ - see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2007.04.012thus leading to increased cytosolic [Ca2+] and stimulation of
contractile elements of the heart muscle cell.
Recent investigations, however, demonstrate that CTS
interacting with the sodium pump also induce complex
signaling cascades in various cells that lead to a multiplicity
of effects [1–4]. In various cancer cell lines, including prostate
cancer cells or breast tumor cells, CTS induce apoptosis [1,4]
and could therefore be candidates for therapeutic agents.
Neuroblastoma is a neoplasm that develops from neural crest
cells and affects one in 7000 children in the USA [5]. The disease
is associated with a poor prognosis for patients older than 1 year,
and a favorable or unfavorable prognosis is associated with the
degree of differentiation [6]. The continuously dividing nor-
adrenergic neuroblastoma cell line SH-SY5Y has often served as
a model in the investigation of neurodegenerative disorders such
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with retinoic acid [9], phorbol ester [10], or neurotrophic factors
[11], SH-SY5Y cells can be induced to differentiate into neu-
ronal cells.
Since the effects that are induced by the various CTS seem to
depend on the cell type investigated, we looked at the effect of
the CTS ouabain on SH-SY5Y cells. Our findings point towards
new fields of research with the perspective of evaluating a
potential introduction of CTS as anti-cancer agents in the treat-
ment of malignancies.
2. Materials and methods
2.1. Culture of SH-SY5Y cells
If not otherwise specified, SH-SY5Y cells (ATCC, Manassas, VA, USA)
were suspended in 10 ml of a solution made of a 1:1 mixture between EMEM
(ATCC) and Ham's F12 (F12K; ATCC) growth media (90%) and fetal calf
serum (FCS; 10%) including 100 U/ml streptomycin and 100 U/ml penicillin.
Cells were incubated at 37 °C under 5% CO2, and the medium was replaced
every 4 days. Experiments were started after the 10th day of incubation (3rd
passage).
2.2. Ouabain effect on cytosolic 86Rb+ and Na+ of SH-SY5Y cells
SH-SY5Y cells were incubated in 12-well dishes until they reached 90%
confluency. The experiment was started by replacing the medium with fresh
growth medium containing various concentrations of ouabain. The medium
contained 130 mM NaCl and 5.4 mM KCl. After 30 min of incubation, 1 μCi of
86RbCl was added to each well, and incubation was continued for another
30 min. Over this period of time 86RbCl uptake is linear, as determined in
preliminary experiments (data not shown). In a different set of experiments, cells
were incubated with either 10 nM or 1 μm ouabain for various times (up to 3 h).
The CTS was then removed, and 1 μCi of 86RbCl in fresh medium was added to
each well. Here, too, incubation was continued for another 30 min. The medium
was then aspirated and the cells washed three times with ice-cold 0.1 M MgCl2
to stop pump activity and remove excess 86Rb+. The washed cells were then
disrupted by treatment with 10% (w/v) trichloroacetic acid (TCA) at 4 °C for 1 h
to release intracellular 86Rb+, and the radioactivity in the lysates was measured
by scintillation counting. Radioactivity obtained with 1 mM ouabain was seen as
nonspecific and was subtracted from other values.
In a different set of experiments, we investigated the effect of ouabain on the
cytosolic Na+ or K+ content. Cells were grown in culture dishes of 10 cm
diameter as described above. After they reached about 80% confluency (10 days
of culture), the medium was removed by aspiration and was replaced by 10 ml of
medium containing various concentrations of ouabain. After 6 h of incubation
the drug was removed, and cells were washed 3 times with ice-cold 0.1 M
MgCl2 and treated with 2 ml of 10% TCA. After 2 h of incubation at 4 °C the
supernatant was collected, centrifuged at 13,000×g for 15 min, and determined
Na+ and K+ content in a flame photometer (Eppendorf, Hamburg, Germany).
The [Na+] or [K+] in the TCA solution was subtracted from all samples.
2.3. Ouabain-stimulated cytosolic Ca2+ elevation and reactive oxygen
species (ROS) generation in SH-SY5Y cells
The fluorescent marker 2′,7′-dichlorodihydrofluorescein diacetate (DCF-
DA; Invitrogen, Karlsruhe, Germany) was used in flow cytometric measure-
ments for assessing the ouabain effect on intracellular ROS generation [12]. For
the measurement of the intracellular level of Ca2+ ions, the calcium-specific dye
FLUO-3-AM (Calbiochem, Schwalbach, Germany) was used in parallel
experiments [13]. The dyes were dissolved in water-free DMSO (Roth,
Karlsruhe, Germany) at a concentration of 100 mM for DCF-DA and 1 mM for
FLUO-3-AM.
SH-SY5Y cells were grown as described above for 10 days until cell layers
reached a confluency of about 80%. After the removal of the growth medium byaspiration, cells were detached from the dishes by the addition of 2 ml of
Trypsin-EDTA solution (ATCC) for 1–2 min. Reaction was then stopped by
adding 6 ml of growth media containing FCS (10%). Cells were collected by
centrifugation at 3000×g for 3 min at room temperature, then suspended in 3 ml
of HBSS buffer containing Ca2+/Mg2+ (Invitrogen).
The cell suspension was then incubated with either 100 μM DCF-DA or
20 μM for FLUO-3-AM for 30 min. Care was taken that the final DMSO
concentration did not exceed 0.1% (v/v). Cell viability was controlled with the
DNA-binding fluorescent dye propidium iodide (PI; Invitrogen), which was
added after the DCF-DA or FLUO-3-AM treatment to the cell suspension at a
final concentration of 20 μM (stock of 1 mM solution in H2O) 5 min before the
measurement. After the loading of the cells with either the ROS- or the Ca2+-
sensitive fluorescent dye including PI, the cell samples were treated with
different concentrations of ouabain. After 30 min of incubation with ouabain,
ROS- and Ca2+-derived fluorescent signals were measured in a flow cytometer
FACSCalibur (Bekton and Dickinson Biosciences, San Jose, CA, USA). For the
DCF signal the excitation wavelength was λEX=495 nm, and the emission was
registered at λEM=520 nm. The FLUO-3-signal was registered λEM=520 nm
by λEX=485 nm. The percentage of dead or necrotic cells was determined
simultaneously from the PI fluorescence (λEX=535 nm; λEM=617 nm) [14].
Each measurement in the flow cytometer referred to 6000 cells. The data
were analyzed using the program WinMDI 2.7. (Scripps Institute, La Jolla, CA,
USA). The population of cells, but not the cell parts, was gated and the level of
ROS and intracellular Ca2+ ions was determined as the mean fluorescence in the
population of viable cells.
2.4. Preparation of cell lysates
SH-SY5Y cells were plated at a density of 5×106 cells in culture dishes of
10 cm diameter and were grown as described above. The cells were then serum-
starved (i.e. 0.5% serum) for 24 h in a medium mixture otherwise prepared as
described above.
Ouabain was added to the cells at various concentrations and the cells were
further incubated at 37 °C for various times. The cells were then lysed using a
commercially available cell lysis buffer (Cell Signaling Technology, Frankfurt,
Germany) according to the protocol of the provider. The lysis buffer contained
20 mM Tris–HCl, pH 7.5, 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1%
Triton (v/v), 2.5 mM sodium pyrophosphate, 1 mM β-glycerophosphate, 1 mM
Na3VO4, and 1 μg/ml leupeptin. Immediately before use, 1 μM PMSF was
added to the lysis buffer. All lysis steps were carried out on ice. After cen-
trifugation of the lysates at 4 °C for 10 min at 13,000×g, the protein in the
supernatant was determined using the bicinchoninic acid (BCA) protein assay
reagent kit (Pierce, Rockford, IL, USA) by including the lysis buffer also in the
standard. Aliquots were stored at −20 °C.
2.5. Preparation of cell lysates for the detection of cytochrome c
(Cytc)
Cell growth conditions and experimental design were the same as above.
Then, after removal of the medium, cells were detached from the dishes by
adding 2 ml of trypsin-EDTA solution (ATCC) for 1 min. After neutralization of
the trypsin action by the addition of 6 ml of growth medium, cells were collected
by centrifugation at 3000×g for 3 min. All following steps were carried out at
4 °C. Harvested cells were washed and suspended in 200 μl of a hypotonic
solution made of 10 mMHBSS, 10 mMMgCl2, 42 mMKCl, 1 μg/ml leupeptin,
1 μg/ml pepstatin, and 1 μM PMSF. Cells were then broken in a glass
homogenizer on ice. After a first centrifugation at 800×g for 10 min, the
supernatant was transferred into a new tube and centrifuged a second time at
15,000×g for 15 min. Protein in the supernatant was determined as described
above, and aliquots were stored at −20 °C.
2.6. SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and
Western blotting of isolated proteins
Proteins of the cell lysates were separated by SDS-PAGE using slab gels of
10% acrylamide and 0.3% N,N′-methylene-bis-acrylamide. A total of 10 μg of
protein was run on each lane. Biotinylated molecular weight markers (Cell
Fig. 1. Effect of ouabain on active 86Rb+ transport by the Na+,K+-ATPase and on
cytosolic [Na+] or [K+]. (A) Cells were incubated for 30 min with various
concentrations of ouabain in growth medium containing 130 mM NaCl and
5.4 mK KCl and were afterwards exposed to 1 μCi of 86RbCl for an additional
30 min. At 10 μM ouabain, 86RbCl uptake still accounts for 33.5±5.3% of the
uptake in the absence of ouabain. The EC50 for the reduction in
86Rb+ transport
is 8.5 μM ouabain (n=5–7±SEM). (B) Determination of cytosolic [Na+] or (C)
[K+] by flame photometry. After 6 h of incubation with 10 μM ouabain cytosolic
[Na+] increases by 33±8.7% and cytosolic [K+] drops by 26.3±4.3% when
compared to the control (n=3±SEM). At 1 μM ouabain changes in [Na+] and
[K+] are more moderate (23±5.8% or 18.8±4.4%, respectively). Finally,
100 nM ouabain does not influence the concentration of the two cations (n=3;
means±SEM; *pb0.05).
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electrophoretic separation, proteins were electro-blotted onto nitrocellulose
membranes (Schleicher & Shull, Dassel, Germany) at 10 V for 30 min.
Western blot detection of phospho- or total Erk1/2, phospho- or total Akt,
and of phospho- or total Bad, Bcl-2, Bcl-XL, Cytc, caspase 3, phospho-p53, or
actin was carried out after electrotransfer by incubating the nitrocellulose
membranes with the appropriate antibodies (all from Cell Signaling Technology)
and following the protocol recommended by the provider. The visualization of
the various proteins was performed by using the appropriate horseradish
peroxidase-conjugated IgG (1:2000 in TBS-T containing 5% nonfat milk)
provided by the enhanced chemiluminescence (ECL) kit (Amersham-Pharma-
cia). A horseradish peroxidase-conjugated anti-biotin IgG (Cell Signaling
Technology) to detect the biotinylated molecular weight marker was also
included in the incubation medium at a dilution of 1:2000. After film exposure,
bands were relatively quantified using a digital documentation system (Biostep,
Jahnsdorf, Germany) and the Phoretix TotalLab gel image analysis software
(Biostep).
2.7. Effect of ouabain on cell growth
SH-SY5Y cells were grown as described above. After serum-starvation (i.e.
0.5% serum) for 24 h, 10 nM or 1 μM ouabain was added to the medium and
incubation continued for various times. Then the incubation medium was
removed, cells were washed once with 10 ml of growth medium, and were
afterwards incubated in growth medium with 10% heat-inactivated FCS. After
4 days of incubation, cells were counted in a Neubauer chamber.
2.8. Effect of ouabain on neuritogenesis
Coverslips of 2.5 cm in diameter were washed for 2 h in 70% ethanol. After
rinsing 4 times with H2O, poly-L-lysine solution (Biochrom AG, Berlin,
Germany) was diluted 1:4.5 with H2O and the glass dishes were incubated in this
solution for 2 h under mild shaking on an orbital shaker. Then the dishes were
dried on filter paper and were stored in the dark at 4 °C until use.
A single poly-L-lysine-coated coverslip was placed on the bottom of culture
dishes of 3.5 cm diameter. About 2.5×104 SH-SY5Y cells in growth medium
containing 10% heat-inactivated FCSwere given into each dish and incubation under
the conditions described above continued for 24 h. Then retinoic acid (RA) at 10 μM
was added to the cultures in the presence or absence of ouabain, and incubation was
continued for an additional 72 h. Untreated cells were grown in parallel.
Afterwards the medium was removed by aspiration and cells were incubated
for 15 min at 37 °C in a solution containing 0.1 mg/ml 4-6-diamidino-2-
phenylindol-di-hydrocloride (DAPI) in methanol. By this treatment cell nuclei
are stained by DAPI by simultaneous cell body fixation. After removing the
methanol solution, poly-L-lysine coated coverslips were washed several times in
PBS and then placed upside down and attached on microscope glass slides by 1
droplet of citiflour (Cityfluor Ltd., London, UK). Cells and corresponding
DAPI-stained nuclei (λEX=340 nm; λEM=488 nm) were documented with a
DCCD camera attached to a fluorescence microscope. Neurite length was
measured in at least 50 randomly chosen cells from every culture.
2.9. Detection of α1, α2 and α3-specific mRNA in SH-SY5Y cells
Total mRNA isolation from cultured SH-SY5Y cells that were grown to
about 75% confluency was performed according to the protocol provided with
the commercially available RNeasy Mini kit (Qiagen, Hilden, Germany). Then
reverse transcription (RT) was performed with the M-MLV RT kit (Promega,
Mannheim, Germany). For the RT, 1 μg of mRNAwas diluted to 15.1 μl with
RNAse-free water. Thereafter, 1 μg of oligo(dT) primers (2 μl) was added to the
solution. That solution was then incubated at 70 °C for 5 min and was afterwards
placed on ice. For the RT reaction of each sample the following mix was
composed: 5 μl of 5× master buffer, 10 mM (1.2 μl) dNTPs, 34 U (0.85 μl)
RNAsin and 200 U (1 μl) M-MLV-RT. The total volume of the mix per sample
was 8.05 μl. 17.1 μl of template and primers was mixed with 8.05 μl of RT mix
and incubated for 60 min at 42 °C. After that the sample was incubated for 3 min
at 93 °C for enzyme inactivation. The sample, now containing cDNA, was
diluted tenfold with H2O and aliquoted.PCR was carried out in a MasterCycler Gradient (Eppendorf, Hamburg,
Germany), by running the following program: after a one-time, initial 5-min
denaturation (95 °C), 40 amplification cycles were carried out by 30 s
denaturation (94 °C), followed by 1 min of primer annealing (60 °C) and 2 min
of amplification (72 °C). PCR was performed with MBI Fermentas (St. Leon-
Rot, Germany) PCR reagents. Each PCR mix was composed by adding 2 μl of
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forward and 1 μl of reverse primer (10 pmol/ml), 1 μl of Taq-polymerase (1 U/
μl) and 10 μl (0.24 μg total) of cDNA template in a total volume of 25 μl with
H2O.
For the specific amplification of α1, forward and reverse primers were
5′CTGGCTGGAGGCTGTCATCTTCTTCAT3′ and 5′GTTGGGGCTCCGAT-
GTGTTGGGGT3′; for α2 5′CTGGCTGGAGGCTGTCATCTTCTTCAT′ and
5′GGCTCTTGGGGGCTGTCTTCTCG-CT3′; for α3 5′CTGGCTGGAGGCT-
GTCATCTTCTTCAT3′ and 5′ATCGGTTGTCGTTGGGGTCCTCGGT3′. The
corresponding fragment sizes are 560, 557 or 560 bp. For controlling the PCR
efficiency and the quality of the cDNA, a GAPDH-specific fragment of 469 bp
was amplified in parallel by applying the primers 5′TGGGGAAGGTGAAGGT-
CGGAGTCAA3′ and 5′TAAGCAGTTGGTGGTGCAGGAGGCA3′.
2.10. Statistical analysis
The significance of the data was analyzed by one way ANOVA and applying
Dunnett's comparison of all columns to the control, and significance was
accepted at pb0.05.3. Results
3.1. Ouabain effect on ATPase pumping activity and on
cytosolic [Na+] or [K+]
In order to distinguish signaling through the pump from
effects that might be due to sodium pump inhibition it was
necessary to determine ouabain concentrations that do not cause
strong alterations in intracellular [K+] or [Na+]. Membrane-Fig. 2. Cytosolic [Ca2+] and ROS levels increase in the cytosol of SH-SY5Y cells treat
Forward (FSC) and side (SSC) light scatter were used to select neuronal population
neuronal populations. B shows the DCF and PI fluorescence, which indicates the leve
AM and PI fluorescence. FLUO-3-AM fluorescence indicates the level of intracellular
Ca2+/Fluo-3 fluorescence at various ouabain concentrations. Bars in panels D and Eextracted human sodium pump isoforms are sensitive to ouabain
and bind the drug with KD values ranging between 13 and
32 nM. On the other hand, binding of ouabain at the surface of
intact cells is influenced by the presence of extracellular K+,
thus resulting in KI values being about 10-fold higher than the
KD values. The human cell line investigated here, however, is
very insensitive to ouabain, as shown in Fig. 1A. Very little
inhibition of active 86Rb+ uptake was obtained up to a concen-
tration of 100 nM ouabain, and even at 1 μM ouabain the
measured radioactivity still accounted for 63.6±8.1% of the
maximum obtained in the absence of ouabain. At 10 μM
ouabain the cytosolic 86Rb+ was 33.5±5.3% of that obtained
with the control cells. This unexpected resistance of the 86Rb+
uptake to ouabain was also observed in parallel experiments
involving Sk-N-AS cells, a different neuroblastoma cell line
(not shown). In an experiment run in parallel, 86Rb+ uptake into
human umbilical vein endothelial cells (HUVEC) was reduced
by about 90% at 10 nM ouabain and was completely blocked at
100 nM ouabain (not shown).
In order to investigatewhether the observed inhibition of active
86Rb+ uptake correlates with changes in the cytosolic Na+ or K+
content, the concentration of these two cations was determined by
flame photometry. Fig. 1B shows that after 6 h of incubation
10 μM ouabain led to an increase in cytosolic [Na+] by only 33±
8.7% above control and at the same time the [Na+] elevation
caused by 1 μMouabain is only 23±5.8% higher than the control.
Similarly, cytosolic [K+] dropped by 18.8±4.4% with 1 μMed with ouabain. Gating criteria were used to divide normal cells from debris. (A)
by cell size and granularity. Panels B and C are examples of analysis of selected
l of ROS and the number of dead cells, respectively, and panel C shows FLUO-3-
calcium. (D) ROS/DCF fluorescence as a function of ouabain concentration. (E)
represent averages of 3 independent experiments (means±SEM; *pb0.01).
Fig. 4. Activation of Akt by ouabain. (A) Cell lysates of SH-SY5Y showing total
Akt. (B) Various concentrations of ouabain cause a modest phosphorylation of
Akt as detected by a specific antibody against Akt phosphorylated at Ser473. (C)
When compared to the control, 10 μM ouabain stimulates phospho-Akt
formation by approximately 35%. The bars show phospho-Akt formation
corrected for corresponding total Akt (n=3; means±SEM; *pb0.05).
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to the control (Fig. 1C). At 100 nMouabain no significant changes
were observed for either cytosolic [Na+] or [K+].
3.2. Effect of ouabain on cytosolic ROS and Ca2+ levels of
SH-SY5Y cells
Ouabain has been shown to induce ROS generation [15–17]
or [Ca2+] elevation [2,18] in various cell systems. The same
observation was made in the current experiments involving the
neuroblastoma cell line SH-SY5Yand the ROS or Ca2+-specific
dyes DCF and FLUO-3, respectively. As shown in Fig. 2,
ouabain at either 1 or 10 μM induced elevations in cytosolic
ROS and Ca2+ that were significantly different from the control.
Maximum ROS elevation obtained at 10 μM ouabain was about
50% above the control, and maximum cytosolic Ca2+ about 25%
higher than in the control. No significant elevation of cytosolic
ROS or Ca2+ was observed after 30min of incubation with either
10 or 100 nM ouabain. In the presence of 1 mM EGTA in the
medium, the cytosolic Ca2+ level dropped to 60% of that of the
control. The additional presence of either 1 or 10 μMouabain did
not influence this value.
3.3. Activation of the Erk1/2 signaling pathway by ouabain
Ouabain has been shown to cause Erk1/2 activation
(phosphorylation) in several cell types [2,4,19–21]. In SH-
SY5Y cells, ouabain stimulates Erk1/2 phosphorylation in a
concentration-dependent manner (Fig. 3). Unlike the rapid Erk1/2
phosphorylation (i.e. 10–30 min) obtained upon ouabainFig. 3. Activation of Erk1/2 by ouabain. After 6 h of incubation with the ouabain
concentrations indicated, SH-SY5Y cells were lysed, and isolated proteins were
separated by SDS-PAGE and probed in a Western blot by antibodies against (A)
total Erk1/2 or (B) phosphorylated Erk1/2. (C) Ouabain induces concentration-
dependent Erk1/2 phosphorylation that at 10 μM reaches a more than three-fold
stimulation compared to the control. Phospho-Erk1/2 formation is compared to
the corresponding total Erk1/2 (bars represent means of 3 independent
experiments±SEM; *pb0.01).treatment of cardiomyocytes [20] or endothelial cells [2], the
ouabain-induced Erk1/2 activation in SH-SY5Y cells occurred in
a delayed manner. Within 30min after the addition of ouabain, no
Erk1/2 phosphorylation was seen (not shown). After 6 h of
incubation of SH-SY5Y cells with ouabain, Erk1/2 phosphory-
lation was clearly detectable (Fig. 3) and persisted for up to 24 h
(not shown). This delayed activation resembles the delayed
activation of Erk1/2 obtained by the treatment of U937 leukemia
cells with 10 μM of the CTS bufalin [19]. In agreement with this
latter study, the ouabain-induced stimulation of Erk1/2 phos-
phorylation in SH-SY5Y cells was also obtained at rather high
ouabain concentrations ranging between 100 nM and 10 μM
(Fig. 3). At these concentrations Erk1/2 phosphorylation was
more then 3-fold higher than in the control.
3.4. Stimulation of Akt phosphorylation by ouabain
Akt (also called PKB) is a protein kinase that plays a crucial
role in controlling the balance between cell survival and apoptosis
[22]. After 6 h of incubation, ouabain stimulated Akt phosphor-
ylation in SH-SY5Y cells at concentrations ranging between 0.1
and 10 μM, which was detected by the use of an antibody that
specifically recognizes the phosphorylated Ser473 of the enzyme
(Fig. 4). The molecular weight of the detected phosphorylated
protein is 60 kDa and corresponds to the expected relative
molecular mass of Akt. In the absence of ouabain, no
phosphorylated Akt was detected. The difference in the amount
of phosphorylated Akt detected was not due to variation in the
total Akt protein since the antibody against total Akt recognized
the protein in similar quantities in all lanes of the Western blot
(Fig. 4). Maximum stimulation of phospho-Akt formation was
seen with 10 μMouabain that was about 35% higher than the Akt
phosphorylation under control conditions.
Fig. 5. Ouabain-induced activation of Bad by phosphorylation at Ser112. Active
Erk1/2 stimulates phosphorylation of pro-apoptotic Bad at Ser112, and active
Akt phosphorylates Ser136 of the protein. The Western blots in the figure show
(A) the presence of total Bad, (B) the Erk1/2-specific phosphorylation of Bad at
Ser112 as a function of ouabain concentration, and (C) the degree of stimulation
by comparing phospho-Bad formation in the presence of ouabain versus control
and by correcting for the corresponding total Bad (n=3; means±SEM;
*pb0.01). Although some phosphorylation was also seen at Ser136, which is
attributed to the Akt pathway, the degree of phosphorylation at this serine
residue was very low and was not investigated further.
Fig. 7. Ouabain-induced release of cytochrome C. (A) The figure shows the
detection of Cytc in the cytosolic fraction of SH-SY5Y cells as a function of
ouabain concentration. (B) Bar diagram summarizing the results from three
independent experiments (means±SEM; *pb0.01).
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the action of ouabain
Bad is a pro-apoptotic member of the Bcl family that can
displace Bax from binding to Bcl-2 and Bcl-XL and, by doing
so, induce apoptosis [23,24]. On the other hand, phosphoryla-
tion of Bad via Erk1/2/P90RSK at Ser112 or via Akt at Ser136Fig. 6. Ouabain-induced down-regulation of anti-apoptotic proteins Bcl-2 and Bcl-X
dependent down-regulation of phospho-Bcl-2 (B) of total Bcl-2 (C) and Bcl-XL (E). T
the total protein, since the actin abundance was not affected by the cardiac steroid (A).
when compared to control without ouabain and after correcting the values for totalpromotes binding of phospho-Bad to the molecular chaperone
protein 14-3-3 and prevents it from binding to Bcl-XL or Bcl-2.
This leads to inhibition of apoptosis and to the support of the
survival pathways [24,25].
Since ouabain acting on SH-SY5Y cells was shown to
activate Erk1/2 and Akt by phosphorylation, we investigated
whether phospho-Bad can also be detected upon treatment of the
cells with ouabain.
The Western blot shown in Fig. 5 demonstrates that ouabain
treatment of the cells for 6 h results in phosphorylation of Bad.
The use of antibodies against either phosphoserine 112 or 136
demonstrated the presence of both phosphoserines. The signal
obtained by using the antibody against phosphoserine 112,
however, was prevalent. The results obtained by using theL. The Western blots shown demonstrate that ouabain induced a concentration-
his down-regulation of the two proteins does not reflect a generalized decrease of
Panels D and E show the ouabain-induced down-regulation of Bcl-2 and Bcl-XL
actin in the corresponding preparations (n=3; means±SEM; *pb0.01).
Fig. 8. Ouabain-induced activation of caspase 3. Procaspase 3 (35 kDa) is
converted to active caspase 3 (p17/19) by various pro-apoptotic signals that
involve Cytc release from the mitochondrial inter-membrane space. As shown in
the Western blot presentation of this figure, ouabain clearly stimulates the
formation of the active caspase peptides p17/19 at concentrations between
100 nM and 10 μM, thus indicating the triggering of the apoptotic machinery.
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shown. The weak phosphorylation at Ser136 might be the result
of the weak Akt phosphorylation (only 35% above control).
3.6. Detection of the anti-apoptotic proteins Bcl-XL and Bcl-2
in SH-SY5Y cells treated with ouabain
Besides the pro-apoptotic protein Bad, the Bcl family also
includes anti-apoptotic members like Bcl-2 or Bcl-XL [24].
Hyperphosphorylated Bcl-2 precludes apoptosis [26]. On the
other hand, down-regulation of either Bcl-2 or Bcl-XL was
shown to induce cell death in glioblastoma cells [27]. In SH-
SY5Y cells, increased or decreased expression of Bcl-2 protein
is associated with prevention or induction of apoptosis, res-
pectively [28]. Therefore, we were interested in investigating
the effect of ouabain on expression of Bcl-XL and Bcl-2 and on
the phosphorylation state of the latter.
The Western blot shown in Fig. 6 demonstrates that after 6 h of
incubation, ouabain causes a decrease of the quantity of Bcl-2
phosphorylated at Ser70 (Fig. 6B). This decrease, however, is veryFig. 9. Ouabain-induced activation of p53. (A) Actin detection in the Western
blot serves as a loading control. (B) The Western blot demonstrates that the
specific phosphorylation of the tumor-suppressor protein p53 at Ser15 is
stimulated by ouabain. (C) Bar diagram showing the activation of p53
phosphorylation at Ser15 as a function of ouabain concentration. Densitometry
values were compared to the control without ouabain and were corrected for
total actin in the corresponding preparations (n=3; means±SEM; *pb0.01).likely not the result of a stimulated phosphatase but rather associ-
atedwith the down-regulation of the total Bcl-2 protein (Fig. 6C,D).
In parallel, an ouabain concentration-dependent down-regulation
was also observed for the Bcl-XL protein (Fig. 6E, F). No changes
were observed in the expression of actin (Fig. 6A).
3.7. Ouabain-induced cytochrome c (Cytc) release
The anti-apoptotic proteins Bcl-XL and Bcl-2 are thought to
prevent apoptosis by interacting with and preventing Bak and
Bax, respectively, from formation of the permeability transition
pore in the outer mitochondrial membrane and release of pro-
apoptogenic factors like Cytc. Since ouabain induces a down-
regulation of both Bcl-2 and Bcl-XL, we investigated whether
the reduction of the anti-apoptotic proteins would result in
release of Cytc to the cytosol. As expected from the known
interrelationships between Bcl-XL/Bad and Bcl-2/Bax, the
reduction of Bcl-2 and Bcl-XL is associated with the appearance
of Cytc in the cytosol (Fig. 7). The increase in cytosolic Cytc
protein is clearly ouabain concentration dependent andFig. 10. Cell number reduction initiated by ouabain preincubation of SH-SY5Y
cells. (A) Cells were incubated for the times indicated with either 10 nM or 1 μM
ouabain. The drug was then removed and 1 μCi of 86Rb+ in medium was added
to each well and incubation continued for an additional 30 min. (B) SH-SY5Y
cells were incubated with either 10 nM or 1 μM ouabain for various times and
were further incubated in medium containing heat-inactivated FCS after the
removal of the cardioactive steroid. After 4 days of incubation, cells were
collected and counted in a Neubauer chamber. Although 10 nM ouabain did not
cause any reduction in 86Rb+ uptake, the cell count significantly decrease after
4 days of incubation.
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apoptotic proteins Bcl-2 and Bcl-XL (Fig. 7).
3.8. Ouabain-induced activation of caspase 3
Caspase 3 is a key determinant of apoptosis. In order to become
activated, it requires proteolytic fragmentation of its inactive
zymogen of 35 kDa to the active p17 and p12 subunits. Caspase 3
can become activated by various pathways, including by Cytc via
caspase 9. Thus, as expected from the previous experiment, ouabain
treatment of the SH-SY5Y cells for 6 h is associated with caspase 3
activation in a concentration-dependent manner (Fig. 8): below the
35-kDa zymogen in the Western blot, the ouabain-induced
formation of the active large fragment (17/19 kDa) is visible.
3.9. Ouabain-induced phosphorylation of p53
The p53 protein, the product of the tumor-suppressor gene
p53, is usually sustained in an inactive form [29]. It becomes
activated by phosphorylation when cells are stressed or damaged,
and as a result p53 stops themultiplication of the damaged cells by
inhibiting their progress through the cell cycle [30]. In addition,
p53 might induce programmed cell death [31,32]. Because
phosphorylation of p53 at Ser15 (and other serines as well) plays
role in regulating p53-mediated apoptotic activity [33], we
determined the phosphorylation status of the protein by using a
specific antibody that recognized this phosphorylation site only.
Fig. 9 shows the ouabain-dependent stimulation of p53
phosphorylation at Ser15. The stimulation of phosphorylation at
1 or 10 μMouabain is about 75% above the signal obtained under
control conditions. The presence of other phosphorylation sites
was not investigated and cannot be excluded.Fig. 11. Ouabain effect on RA-induced neuritogenesis. (A) The figure shows the q
±SEM; *pb0.01). (B–D) Photographs of untreated (B), RA-treated (C), and (RA+
visualized by DAPI staining.3.10. Ouabain effect on cell growth and viability
Down-regulation of the anti-apoptotic proteins Bcl-XL and
Bcl-2 in glioblastoma cells [27] and down-regulation of Bcl-2 in
SH-SY5Y cells [28] are associated with cell death. Since
ouabain induces down-regulation of both proteins, we investi-
gated the effect of ouabain on the growth and viability of SH-
SY5Y cells. In order to determine whether the previously
observed Bcl-2 and Bcl-XL down-regulation would be
sufficient to influence cell viability and growth, ouabain at
10 nm or 1 μMwas added to cell cultures and then after various
times removed by exchanging the media. In order to ensure
sufficient supply of nutrients and to avoid the presence of
growth factors that might influence the outcome of the
experiment, further incubation of the cells was carried out in
media containing 10% heat-inactivated FCS (see Materials and
methods). The cells were observed every 24 h and were
collected and counted on the fourth day after the ouabain pulse.
The number of neuroblastoma cells was considerably reduced
after treatment with ouabain (Fig. 10A). Thus, pre-treatment
with 1 μM ouabain for 180 min caused about a 75% reduction
of cell number, whereas at the same time pre-treatment with
10 nM ouabain caused a reduction of cell number by about 20%.
3.11. Prevention of retinoic acid-induced neuritogenesis of
SH-SY5Y cells by ouabain
Retinoic acid (RA), an active metabolite of vitamin A,
induces neuronal differentiation of SH-SY5Y cells [34]. One
first indication for the progress of differentiation is formation of
long neurites [34]. RA-induced differentiation of SH-SY5Y
cells seems also to be associated with up-regulation of Bcl-2 anduotient of neurites longer than 50 μm divided by the cells counted (n=50–65;
ouabain)-treated (D) SH-SY5Y cells. Bar length represents 50 μm. Nuclei were
Fig. 12. Expression of Na+,K+-ATPase α subunit isoform-specific mRNA
(cDNA) in SH-SY5Y cells. mRNA was isolated from SH-SY5Y cells and
transcribed into cDNA. Using specific primers for the α1, α2, and α3 isoforms
of the sodium pump α subunit, PCR amplification was carried out over 36 or 40
amplification cycles. The α2 isoform was detectable after only 40 amplification
cycles. Amplification of the GAPDH-specific signal was carried out as a control
for the mRNA isolation and PCR amplification procedure.
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apoptosis [35]. The same observation was made when SH-
SY5Y cells were transfected with a plasmid harboring a Bcl-2
deletion mutant lacking its mitochondrial docking terminus.
In the experiments shown in Fig. 11, incubation of SH-SY5Y
with 10 μM retinoic acid promotes neuritogenesis readily
visible after 72 h of incubation in medium containing 10% heat-
inactivated FCS. Ouabain at 100 nM simultaneously present
with 10 μMRA completely inhibited neuritogenesis to the level
of untreated controls. Higher ouabain concentrations were
avoided because they resulted in great numbers of dead cells.
3.12. Detection of mRNA (cDNA) coding for the subunit
isoforms α1, α2 or α3 of human Na+,K+-ATPase
The physiological role of the various isoforms of the
subunits of the Na+,K+-ATPase has not yet been elucidated.
Cell signaling cascades have been detected in cells that express
only a single isoform of the α subunit [2] as well in such that
express multiple isoforms [36]. Thus, we wished to identify the
isoforms of the α subunit that are expressed in the neuroblas-
toma cell line SH-SY5Y. Fig. 12 demonstrates the presence of
all three isoforms investigated. The neuron-specific, α3-specific
mRNA (cDNA) seems to be the dominant form, followed by the
ubiquitous α1-specific isoform. α2-specific mRNA is also
present and accounts for about 10% of the α1-specific mRNA
(cDNA) isoform.
4. Discussion
Besides regulating the electrochemical gradient of animal
cells, Na+,K+-ATPase activates various signaling cascades upon
interaction with CTS in different cell types [37–39]. Exposure
of malignant breast cancer cells [4], prostate carcinoma cells
[1,40,41], human leukemia cells [19] or neuronal cells [42] to
various CTS leads to cell death, thus offering the possibility of
using CTS not only for the well-known treatment of congestive
heart failure but also for treatment of malignancies.
In children, extracranial neuroblastoma is the most common
solid tumor, followed by leukemias, brain and central nervous
system tumors, and retinoblastoma [5]. While most infants withdisseminated neuroblastoma may be successfully treated by
chemotherapy and surgery, the prognosis for patients older than
1 year with advanced-stage disease is very poor [6]. Neverthe-
less, only 12% of neuroblastomas are diagnosed within the first
month of life [5].
The neuroblastoma-derived cell line SH-SY5Y has often
been used for investigating mechanisms involved in apoptosis
[8,35,43], and because under circumstances they can differen-
tiate into neuronal cells [44], they have also served as a model in
the investigation of neurodegenerative disorders such as
Alzheimer's and Parkinson's diseases [7,45].
Recently, ouabain was shown in in vivo experiments
involving mice to induce dual effects, depending upon the
concentration applied. Thus, nanomolar or micromolar concen-
trations initiated and potentiated excitotoxicity induced by
kainite; subnanomolar concentrations, however, reduced the
kainite-induced neuronal apoptosis [46]. Applied at 80 μM
ouabain was shown to induce concurrent apoptosis and necrosis
in cultured cortical neurons [47]. These various effects all
induced by ouabain emphasize the need for further investigating
the role of Na+,K+-ATPase as a CTS receptor in the regulation of
neuronal cell physiology.
In the current investigation, we focus on the effects of
ouabain on the human-derived neuroblastoma cell line SH-
SY5Y. Ouabain was shown in an earlier investigation to produce
cell damage of SH-SY5Y at 10 μM, possibly by inducing
apoptosis indicated by detected DNA fragmentation [42]. In
order to define a concentration range for ouabain we investigated
the effect of the drug on the active, sodium pump-mediated K+
uptake into the cytosol of the SH-SY5Y cells. This was done by
using 86Rb+ as a surrogate for K+. Since all human sodium pump
isoforms are considered CTS sensitive, we expected to see a
complete inhibition of active 86Rb+ uptake at rather low
concentrations of ouabain, as observed previously [2]. However,
ouabain inhibited 86Rb+ uptake with an unexpectedly high EC50
value of 8.5 μM (n=5–7±SEM; Fig. 1A). At 10 μM ouabain,
active 86RbCl uptake still accounted for 33.5±5.3% of the
uptake in the absence of ouabain. These values that are higher
than known KD values for the interaction of sodium pump
isoforms with ouabain [48] can be in part explained by the well-
known fact that K+ (which is present in the growth medium at
5.4 mM) reduces ouabain binding to the enzyme. This, however,
cannot be the only reason for the high EC50 value obtained, since
with other cells half-maximal inhibition of 86Rb+ uptake is
obtained at much lower concentrations under conditions that are
otherwise similar to those used here [4]. In a series of parallel
experiments that are not presented here in detail, 86Rb+ uptake
into HUVECwas completely inhibited at 100 nMouabain, while
a strong resistance was seen with Sk-N-As cells. The reason for
the higher resistance of the neuroblastoma cell towards ouabain
is not yet known. Experiments involving different malignant
cells, however, indicate a reduced abundance of sodium pumps
in the plasma membrane [49–51].
We also determined that ouabain causes modest changes in
the cytosolic Na+ or K+ concentration in SH-SY5Y cells. Even
after 6 h at 10 μM ouabain, the Na+ increase is only 33±8.7%
above control, and at 100 nM it is almost identical to the control
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in cytosolic K+ by 26.3±4.3% as compared to the control
(Fig. 1C). These data indicate that despite the relatively strong
inhibition of the active 86Rb+ uptake by ouabain, the cytosolic
ion composition is not that strongly affected, since other
transporters also contribute to cytosolic Na+ and K+ concentra-
tions. It is known from a series of experiments that partial
inhibition of the sodium pump does not necessarily lead to large
changes in intracellular [Na+] or [K+], a phenomenon attributed
to a reserve capacity of the sodium pump [4]. In our
experiments 1 μM ouabain does not considerably affect the
intracellular ratio of K+ to Na+. For this reason, and because
even at 10 μM ouabain we still see a considerable amount of
sodium pump activity, we also included these concentrations of
ouabain in our further investigations. Nevertheless, some
observations in this study might be attributed to the K+ loss at
higher ouabain concentrations.
Within the first 6 h of incubation, ouabain activates a variety of
signaling cascades and considerably affects cell growth and
survival. So-called survival pathways are triggered that involve
activation of Erk1/2 and Akt and phosphorylation and inactiva-
tion of the pro-apoptotic protein Bad. Although activation of
Erk1/2 [2,4,19–21] and Akt [52] by CTS has been observed in
various cell systems, to our knowledge ouabain-induced Bad
phosphorylation has not been described before.
Erk1/2 activation is usually associated with early events of
signal transduction and constitutes a key event for the
proliferation and differentiation of cells [53]. The ouabain-
induced Erk1/2 activation in SH-SY5Y cells, however, is
unusual. While in most cell systems Erk1/2 activation occurs
within 10–20 min after application of an extracellular
stimulatory signal, in SH-SY5Y cells no Erk1/2 phosphorylation
was observed with the first 30 min. In cell lysates isolated after
6 h or 24 h, however, phospho-Erk1/2 was clearly detectable and
reached a 3-fold higher level at 10 μM ouabain compared to
control. This observation is in good agreement with bufalin-
induced Erk1/2 phosphorylation in U937 leukemia cells [19].
Active Erk1/2 (via P90RSK) and Akt can phosphorylate the
pro-apoptotic protein Bad at Ser112 and Ser136, respectively.
Phosphorylated Bad is incapable of inducing apoptosis. It
interacts rather with the molecular chaperone protein 14-3-3 to
support survival pathways [24,25]. Since ouabain induces Bad
phosphorylation, one would assume it suppresses apoptotic
pathways in SH-SY5Y cells. Nevertheless, in mature hippo-
campal neurons sustained activation of Erk1/2 by the fibrillar
protein β-amyloid triggers neurodegeneration [54], and inhibi-
tion of the Erk1/2 signaling pathway reduces neuronal death in a
hippocampal neuron-culture model of seizure activity [55].
Numerous other investigations provide evidence that in neuronal
cells Erk activation is associated with cell death which might be
considered as non-apoptotic [56], although a precise distinction
between apoptosis and necrosis has been becoming increasingly
difficult due to the fact that both mechanisms of cell death share
common characteristics. In addition, cell survival or cell death is
the result of the balance or imbalance of multiple parameters.
Thus, in parallel to the activation of the Erk1/2 pathway in SH-
SY5Y cells, we observe an ouabain-induced down-regulation ofthe anti-apoptotic proteins Bcl-2 and Bcl-XL. The mechanism
by which the proteins Bcl-XL and Bcl-2 prevent apoptosis is not
yet entirely clear. In a recent study, however, it was shown that
Bcl-XL, by interacting with Bak, prevents the latter from
forming pores in the outer mitochondrial membrane and causing
the release of pro-apoptogenic factors like cytochrome c [57].
Bcl-2 seems to prevent Cytc release from mitochondria by
binding to Bax, a protein that when activated also promotes the
formation of the permeability transition pore in the outer
mitochondrial membrane [58,59].
In the experiments presented here, ouabain induced down-
regulation of Bcl-XL and Bcl-2. Interestingly, Bcl-2 over-
expression was shown to stimulate sodium pump activity in a
human B-cell lymphoma cell culture [60]. Down-regulation of
Bcl-XL and Bcl-2 is associated with the appearance of Cytc in the
cytosol, most likely as the result of the formation of the
permeability transition pore in the outer mitochondrial membrane
by unrestrained Bak and Bax proteins. Our observation is in good
agreement with results showing that various digitalis compounds
also cause Cytc release into the cytosol in HeLa cells [61]. In
addition, p53 phosphorylation at Ser15was detected as a function
of ouabain concentration (Fig. 8). Active p53 can induce
programmed cell death [31,32], and phosphorylation of p53 at
Ser15 plays a role in regulating p53-mediated apoptotic activity
[33]. Althoughwe do not knowwhether Ser15 phosphorylation of
p53 might also be involved in the inhibition of cell cycle
progression and therefore cell division [30], it is likely that
phosphorylation of p53 on Ser15 and translocation of Cytc to the
cytosol induce the initiation of events that lead to apoptosis.
Accordingly, we observe that a 3-h pulse of ouabain treatment
results in a 75% reduction in the SH-SY5Y cell count after 4 days.
Apparently, the apoptotic events initiated by ouabain in the course
of short-term treatment of SH-SY5Y cells dominate the
simultaneously occurring survival signals.
This idea is consistent with our findings showing an early
generation of ROS and the early elevation of cytosolic [Ca2+]
induced by ouabain (Fig. 1). ROS generation has been shown to
be associated with the induction of apoptosis in neuronal and
other cell types [62–64]. It has long been known that Ca2+
signals regulate a series of important cell functions associated
with cell survival. Nevertheless, recent evidence demonstrates
that Ca2+ can induce either apoptotic or necrotic cell death [65].
In undifferentiated neurons, Ca2+ seems to trigger apoptotic
pathways [66]. It might be that the ouabain-induced elevation of
both ROS and cytosolic [Ca2+] in SH-SY5Y synergistically
triggers the apoptotic events. On the other hand, based on the
Erk1/2 activation [54–56], we cannot exclude a simultaneous
occurrence and overlap of non-apoptotic and apoptotic events
that lead to cell death.
Expression levels of Bcl-2 and Bcl-XL are a key parameter
associated with the differentiation of SH-SY5Y cells induced by
retinoic acid [35]. Differentiation, defined as the RA-induced
degree of neuritogenesis [34], is associated with up-regulation of
Bcl-2 and Bcl-XL. Down-regulation of Bcl-2 induced by siRNA
inhibits differentiation of SH-SY5Y and results in increased
apoptosis [35]. In the current investigation, ouabain completely
inhibited RA-induced neuritogenesis of SH-SY5Y cells (Fig. 11)
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or cell death. The primary signal for both phenomenamight be the
observed down-regulation of the anti-apoptotic proteins Bcl-XL
and Bcl-2 and the stimulation of p53 phosphorylation. This is the
first time that a down-regulation of Bcl-XL and Bcl-2 and a
stimulation of p53 phosphorylation by ouabain have been
reported; the specific mechanisms that lead to these events,
however, have yet to be investigated. In addition, assuming that
the sodium pump, which is the only known receptor for CTS, is
involved in the signaling process, it will be of interest to elucidate
which of the isoforms of the sodium pump α subunits is involved
in the signaling process. According to a previous publication,
undifferentiated SH-SY5Y cells express only α1 subunits on the
protein level and start co-expressing α3 subunits when
differentiated; the α2 isoform was not detected by specific
antibodies in this report [67]. Nevertheless, on the mRNA level,
we find that α1-, α2-, and α3-specific mRNAs are all present in
the undifferentiated cells. The α2–specific mRNA, however, is
present at a low abundance, and this might be the reason why
detection by an anti-α2 antibody was not possible in a Western
blot [67]. Studies involving siRNA to selectively silence each of
the α subunit isoforms might deliver more conclusive results
concerning the participation of isoforms in the signaling cascade.
Nevertheless, the possibility exists that there are alternative
receptors for CTS other than the Na+,K+-ATPase [68].
A series of investigations, including the one presented here,
indicate that ouabain and other cardiac steroids at low
concentrations act like hormones that can trigger a variety of
signalling cascades in various cell lines. Understanding the
mechanisms by which these signals are mediated will be critical
for assessing a possible therapeutic use of these substances in
the treatment of not only cardiac dysfunctions but also of
various types of malignancies.
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